Civic Intelligence

Clayton Foundation for Research

EIN 74-1541767 • 501(c)3 • Houston, TX

Profile

The primary mission is to conduct medical research in conjunction with hospitals for the purpose of discovering the cause, prevention and cure of diseases for the benefit of mankind. The secondary mission is to transfer the resulting medical research discoveries from the laboratory to the use of the general public by patenting and licensing such technology for devlopment into drugs or other products for the use and benefit of mankind through the Foundation's supporting entities.

One Riverway 1500Houston, TX 77056

n/A

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

19th percentile

0.05x

Higher debt load relative to assets than 19% of similar nonprofits.

501(c)3 • $100M-$250M nonprofits • Source year 2024

Liabilities / Revenue

51st percentile

0.44x

Higher debt load relative to revenue than 51% of similar nonprofits.

501(c)3 • $100M-$250M nonprofits • Source year 2024

Net Margin

81st percentile

26%

Higher net margin than 81% of similar nonprofits.

501(c)3 • $100M-$250M nonprofits • Source year 2024

Top Officer Pay

Score unavailable

No value available

No filing with officer rows is available for this organization yet.

Asset Growth

67th percentile

11%

Faster asset growth than 67% of similar nonprofits.

501(c)3 • $100M-$250M nonprofits • Annualized from 2023 to 2024

Revenue Growth

86th percentile

35%

Faster revenue growth than 86% of similar nonprofits.

501(c)3 • $100M-$250M nonprofits • Annualized from 2023 to 2024

Assets

Up

$144,353,789

Up $13,781,321 (+11%) from 2023

Liabilities

Down

$6,584,095

Down $536,943 (-7.5%) from 2023

Net Assets

Up

$137,769,694

Up $14,318,264 (+12%) from 2023

Revenue

Up

$14,857,333

Up $3,813,543 (+35%) from 2023

Expenses

Up

$10,938,202

Up $187,672 (+1.7%) from 2023

Net Income

Up

$3,919,131

Up $3,625,871 (+1236%) from 2023

Trend Graphs

Balance Sheet Trend

Grouped bars show assets, liabilities, and net assets across loaded filings.

$150M$100M$50M$0Assets 2011: $67,995,923Liabilities 2011: $3,060,130Net Assets 2011: $64,935,7932011Assets 2012: $75,860,692Liabilities 2012: $3,027,181Net Assets 2012: $72,833,5112012Assets 2013: $84,129,457Liabilities 2013: $3,387,003Net Assets 2013: $80,742,4542013Assets 2014: $88,750,003Liabilities 2014: $4,018,943Net Assets 2014: $84,731,0602014Assets 2015: $85,320,054Liabilities 2015: $4,130,008Net Assets 2015: $81,190,0462015Assets 2016: $83,784,554Liabilities 2016: $4,413,129Net Assets 2016: $79,371,4252016Assets 2017: $94,486,324Liabilities 2017: $4,517,809Net Assets 2017: $89,968,5152017Assets 2018: $90,477,419Liabilities 2018: $4,366,501Net Assets 2018: $86,110,9182018Assets 2019: $109,628,733Liabilities 2019: $4,958,403Net Assets 2019: $104,670,3302019Assets 2020: $120,838,913Liabilities 2020: $5,282,505Net Assets 2020: $115,556,4082020Assets 2021: $144,911,994Liabilities 2021: $5,575,165Net Assets 2021: $139,336,8292021Assets 2022: $112,685,763Liabilities 2022: $7,117,332Net Assets 2022: $105,568,4312022Assets 2023: $130,572,468Liabilities 2023: $7,121,038Net Assets 2023: $123,451,4302023Assets 2024: $144,353,789Liabilities 2024: $6,584,095Net Assets 2024: $137,769,6942024

Highlighted filing

2024

Assets$144,353,789
Liabilities$6,584,095
Net Assets$137,769,694

Operations Trend

Revenue, expenses, and net income by year, with the latest filing highlighted.

$20M$10M$0-$10MRevenue 2011: $6,669,105Expenses 2011: $7,607,121Net Income 2011: -$938,0162011Revenue 2012: $5,591,196Expenses 2012: $7,281,423Net Income 2012: -$1,690,2272012Revenue 2013: $4,668,048Expenses 2013: $8,151,233Net Income 2013: -$3,483,1852013Revenue 2014: $17,850,955Expenses 2014: $8,750,687Net Income 2014: $9,100,2682014Revenue 2015: $9,311,936Expenses 2015: $9,414,275Net Income 2015: -$102,3392015Revenue 2016: $9,640,867Expenses 2016: $9,442,942Net Income 2016: $197,9252016Revenue 2017: $10,978,866Expenses 2017: $9,058,019Net Income 2017: $1,920,8472017Revenue 2018: $10,448,996Expenses 2018: $9,582,154Net Income 2018: $866,8422018Revenue 2019: $17,310,509Expenses 2019: $9,783,230Net Income 2019: $7,527,2792019Revenue 2020: $10,487,160Expenses 2020: $9,206,656Net Income 2020: $1,280,5042020Revenue 2021: $10,982,705Expenses 2021: $10,317,749Net Income 2021: $664,9562021Revenue 2022: $6,604,622Expenses 2022: $10,006,620Net Income 2022: -$3,401,9982022Revenue 2023: $11,043,790Expenses 2023: $10,750,530Net Income 2023: $293,2602023Revenue 2024: $14,857,333Expenses 2024: $10,938,202Net Income 2024: $3,919,1312024

Highlighted filing

2024

Revenue$14,857,333
Expenses$10,938,202
Net Income$3,919,131

Filings

Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$144$6.58$138$14.9$10.9$3.92
2023XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$131$7.12$123$11.0$10.8$0.29
2022Facts available. Structured filing facts are available, but richer extracted sections are limited.$113$7.12$106$6.60$10.0$3.40
2021XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$145$5.58$139$11.0$10.3$0.66
2020XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$121$5.28$116$10.5$9.21$1.28
2019Summary only. Only limited summary data is available for this year.$110$4.96$105$17.3$9.78$7.53
2018Summary only. Only limited summary data is available for this year.$90.5$4.37$86.1$10.4$9.58$0.87
2017Summary only. Only limited summary data is available for this year.$94.5$4.52$90.0$11.0$9.06$1.92
2016Summary only. Only limited summary data is available for this year.$83.8$4.41$79.4$9.64$9.44$0.20
2015Summary only. Only limited summary data is available for this year.$85.3$4.13$81.2$9.31$9.41$0.10
2014Summary only. Only limited summary data is available for this year.$88.8$4.02$84.7$17.9$8.75$9.10
2013Summary only. Only limited summary data is available for this year.$84.1$3.39$80.7$4.67$8.15$3.48
2012Summary only. Only limited summary data is available for this year.$75.9$3.03$72.8$5.59$7.28$1.69
2011Summary only. Only limited summary data is available for this year.$68.0$3.06$64.9$6.67$7.61$0.94
Latest Detailed Filing

The latest 2024 filing currently has linked XML that has not been fully parsed yet. Showing the latest detailed filing from 2022 below.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2022 to Dec 31, 2022
Signed
Nov 15, 2023
Return Version
2022v5.0
Gross Receipts
$7,712,468
Mission and Program Overview

Mission

The primary mission is to conduct medical research in conjunction with hospitals for the purpose of discovering the cause, prevention and cure of diseases for the benefit of mankind. The secondary mission is to transfer the resulting medical research discoveries from the laboratory to the use of the general public by patenting and licensing such technology for devlopment into drugs or other products for the use and benefit of mankind through the Foundation's supporting entities.

The primary mission is to conduct medical research in conjunction with hospitals for the purpose of discovering the cause, prevention and cure of diseases for the benefit of mankind.

Balance Sheet Detail
LineBeginningEndChange
Assets
Investments in Publicly Traded Securities$112,865,433$82,679,826▼ $30,185,607
Land, Buildings, and Equipment, Net$145,430$2,941,572▲ $2,796,142
Cash and Non-Interest-Bearing Accounts$1,775,261$572,693▼ $1,202,568
Accounts Receivable$270,377$284,990▲ $14,613
Prepaid Expenses and Deferred Charges$175,385$154,984▼ $20,401
Savings and Temporary Cash Investments-$0-
Other Notes and Loans Receivable, Net-$0-
Pledges and Grants Receivable-$0-
Receivable From Disqualified Prsn-$0-
Receivables From Officers Etc-$0-
Investments Other Securities-$0-
Investments Program Related-$0-
Intangible Assets-$0-
Inventories for Sale or Use-$0-
Total Assets$144,911,994$112,685,763▼ $32,226,231
Other Assets Total$29,680,108$26,051,698▼ $3,628,410
Liabilities
Accounts Payable and Accrued Expenses$5,575,165$7,117,332▲ $1,542,167
Total Liabilities$5,575,165$7,117,332▲ $1,542,167
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$97,112,182$65,038,437▼ $32,073,745
Net Assets With Donor Restrictions$42,224,647$40,529,994▼ $1,694,653
Total Net Assets Fund Balance$139,336,829$105,568,431▼ $33,768,398
Total Liabilities and Net Assets / Fund Balance$144,911,994$112,685,763▼ $32,226,231

Asset Categories

AssetBook ValueDepreciationBasis
Other Land Buildings$2,827,193$361,133$3,188,326
Equipment$68,241$687,878$756,119
Leasehold Improvements$46,138$443,978$490,116
Other Assets Org$24,431,901--

Endowment Activity

PeriodBeginningContrib.Gain/LossOther UsesEnd
2022$39,166,467---$39,166,467
2021$39,166,467---$39,166,467
2020$39,166,467---$39,166,467
2019$39,166,467---$39,166,467
2018$39,166,467---$39,166,467
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
Jarred W SloanTrustee, President, TreasurerPT$257,354$73,617$330,971
Robert L EvansAssistant TreasurerFT$198,267$63,657$276,727
Robert M WallaceTrustee, Vice PresidentPT$190,957$48,520$254,614
Kimberly A ShipleyAssistant SecretaryFT$165,200$73,500$238,700
Lawrence H CheungProject ResearcherFT$106,475$67,881$174,356
Joshua T ChangProject ResearcherFT$101,077$67,072$168,149
Brian W CrozierTrusteePT$91,375$48,520$139,895
Thomas J BrorbyTrustee, ChairmanPT$91,375$281,375$139,895
Joan S DunlapVice President, Secretary-$53,138$56,691$109,829
Lynn P CarterTrusteePT$91,375$78,460$91,375

Highest Paid Contractors

ContractorServicesLocationCompensation
Brorby Crozier & Dobie PCLegal111 Congress Ave Suite 2250, Austin, TX 78701$498,737
Revenue and Support

Revenue Composition

Contributions and Grants
$3,825,000
Program Service Revenue
$96,250
Investment Income
$2,387,350
Other Revenue
$296,022
Change in Net Assets
$-3,401,998

Audited Revenue Reconciliation

Revenue per Audited Statements
$6,238,861
Revenue Not Reported on Financial Statements
$365,761
Revenue Not Reported on Form 990
$-31,930,432
Other Revenue Adjustments
$55,346
Total Revenue per Audited Statements
$-25,691,571
Total Revenue per Form 990
$6,604,622
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Salaries, Compensation, and Employee Benefits$6,495,102
Other Expenses$3,361,518
Grants and Similar Amounts Paid$150,000
Professional Fundraising Fees$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Other Salaries and Wages$2,479,033$234,937-$2,713,970
Current Officers, Directors, Trustees, and Key Employees$1,310,951$271,055-$1,582,006
Other Employee Benefits$960,774$179,361-$1,140,135
Comp Disqual Persons$373,091$159,896-$532,987
Occupancy$256,404$104,729-$361,133
Pension Plan Contributions$295,466$36,805-$332,271
Fees for Service Investment Mgmnt Fees-$310,415-$310,415
Insurance$203,682$32,910-$236,592
Payroll Taxes$178,171$15,562-$193,733
Grants to Domestic Orgs$150,000--$150,000
All Other Expenses$105,406$35,467-$140,873
Travel$72,823--$72,823
Office Expenses$47,166$19,265-$66,431
Other Expenses$57,931$7,899-$57,931
Fees for Services Accounting$39,759$9,940-$49,699
Depreciation Depletion$22,046$9,005-$31,051
Fees for Services Other$24,518$4,144-$28,662
Fees for Services Legal$444$148-$592
Total Functional Expenses$8,575,082$1,431,538$0$10,006,620

Audited Expense Reconciliation

Line ItemAmount
Total Expenses per Form 990$10,006,620
Total Expenses per Audited Statements$9,740,512
Expenses per Audited Statements$9,696,205
Expenses Not Reported on Financial Statements$310,415
Expenses Not Reported on Form 990$44,307
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
Georgetown UniversityWashington DC, DC501(c)(3)Gen Purpose$15,000
National MS SocietyNew York, NY501(c)(3)Gen Purpose$10,000

International Summary

Spending
$7,559,473

International Compliance

Activity in boycott countries
No
Foreign corporation ownership
Yes
Foreign partnership interest
No
Interest in foreign trust
No
Passive foreign investment company interest
Yes
Transfers to foreign corporations
Yes

International Activities

RegionActivityServicesOfficesEmployeesSpending
Central America and CaribbeanInvestmentsN/a00$7,559,473
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Insider Transactions and Loans

Interested-Person Transactions

Interested PartyRelationshipDescriptionShared RevenueAmount
Brorby Crozier Dobie PCSee schedule OLegal ServicesNo$532,987

Loans and Receivables

Line ItemBeginningEndChange
Receivables from Disqualified Persons-$0-
Receivables from Officers, Directors, Trustees, and Key Employees-$0-
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Backup withholding compliance
Yes
Business relationship with 35% controlled entity
Yes
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
Yes
Conflict-of-interest policy
Yes
Audited financial statements prepared
Yes
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, Line 11B

Form 990 is prepared by the Foundation's accounting staff and sent to the Brorby, Crozier & Dobie law firm for review by a tax partner. Each trustee is given a copy of the return for review by the Treasurer prior to filing. Once satisfied with the content of the Form 990, the trustees approve the return for filing with the Internal Revenue Service, and the return is signed and dated by the appropriate officer of the Foundation.

Form 990, Part VI, Section B, Line 12C

Annually, the trustees and officers review the Conflicts of Interest Policy adopted by the Foundation. At a meeting of the Board each year, both the trustees and the officers sign and date a statement which affirms that such person has received a copy of the conflict of interest policy, has read and understands the policy, has agreed to comply with the policy, and understands that the Foundation is a charitable organization and that in order to maintain its federal tax exemption it must engage primarily in activities which accomplish one of more of its tax-exempt purposes. It is the policy of the Foundation to assure that any conflicts of interest or potential conflicts of interest are fully disclosed to the Board before a decision is made or before the Foundation enters into a proposed transaction. Where necessary to determine whether a conflict of interest exists, after disclosure of the financial interest and all material facts, and after any discussion with the interested person, he or she leaves the Board meeting while the determination of whether a conflict of interest exists is discussed. If the Board determines that a conflict exists, the Board then determines whether the transaction or arrangement is fair and reasonable and should be permitted despite the conflict (or not) as being in the best interests of the Foundation. In instances where the Board has determined that a member has failed to disclose an actual or possible conflict of interest, it will take appropriate disciplinary and/or corrective action.

Form 990, Part VI, Section B, Line 15A

Several written opinions have been obtained from well recognized independent accounting and consulting firms as to the reasonableness of the compensation being paid to the officers and trustees of the Foundation (including amounts paid by related organizations). In addition, all steps listed in the regulations under IRC Section 4958 (including approval by a compensation committee composed of disinterested persons) have been taken to obtain the rebuttable presumption that compensation paid to the trustees and officers is reasonable. More specifically, the Foundation has periodically engaged an independent consulting firm to review the compensation of the officers and trustees of the Foundation and the group of related and supporting entities. Such consulting firm examines the relevant facts and collects information and data from the Foundation. It also collects and analyzes compensation data from a peer group of unrelated non-profit and for-profit organizations that it selects for comparability purposes. Such firm then renders a written report and opinion containing its conclusions and recommendations. Such report (including a thorough description of the facts and the comparability analysis and data) is provided to the Foundations Compensation Committee. Such committee, which has the sole authority to approve officer and trustee compensation, constitutes an authorized body composed of persons that do not have a conflict of interest with respect to such compensation arrangements under the rules and requirements set forth in Reg. 53.4958-6(c)(1). The committee meets and reviews the consulting firm's report and the comparability analysis and data. At the meeting, the committee has the opportunity to ask questions and request additional information from a Foundation representative on the committee (who recuses himself from the meeting before any action is taken). After review of the relevant documents and data and after deliberations, the independent committee members make the determination with respect to the amount and reasonableness of the officer and trustee compensation arrangements. Such determination is binding on the trustees and officers of the Foundation. Detailed minutes of each Compensation Committee meeting are contemporaneously prepared and maintained in the Foundations files.

Form 990, Part VI, Section B, Line 15B

See Line 15 a for the description of the compensation review and approval of other officers or key employees.

Form 990, Part VI, Section C, Line 19

No documents available to the public.

Part 1, Line 4 & Part VI, Line 1B - Independent Voting Members

The recommendation regarding independent members of the governing board of a charity is described and discussed in detail in the report entitled "Principles for Good Governance and Ethical Practice, A Guide for Charities and Foundations", Reference Edition, that was published in October 2007 by the Panel on the Nonprofit Sector. This panel was convened by Independent Sector and its recommendations have been cited with approval by the Internal Revenue Service. Such report concludes that the principle with respect to independent directors does not apply to various types of organizations, including medical research organizations described in IRC 170(b)(1)(A)(iii), such as the Foundation. In this regard, Footnote 27 on page 23 expressly states as follows: "This principle [a substantial majority of the Board should be independent] does not apply to private foundations; medical research institutions...; supporting organizations or subsidiaries that are required by law to include representatives of the supported organizations or sponsoring charities on their board..." [footnote listing continues with several other specific types of Section 501(c)(3) organizations].

Part VI, Section A, Line 2 and Schedule L, Part IV

Mr. Thomas J. Brorby, who became a trustee of the Foundation on July 1, 1998 (and was elected Chairman of the Board effective May 1, 2008), has provided legal services to the Foundation since 1965. Mr. Brian W. Crozier, who became a trustee of the Foundation on January 1, 2019, has provided legal services to the Foundation since 1985. Mr. Brorby and Mr. Crozier are members of the law firm of Brorby, Crozier & Dobie, P.C. ("B,C&D") and together own more than 35% of B,C&D. Such firm is engaged to furnish legal services to the Foundation on an hourly basis in connection with various matters upon the request of Foundation trustees and officers other than Mr. Brorby and Mr. Crozier. The Foundation's relationship with B,C&D pre-dates the naming of either Mr. Brorby or Mr. Crozier as trustees. In their capacity as members of the Board of the Foundation, Mr. Brorby and Mr. Crozier do not participate in any decisions involving assignment of work to B,C&D and are not involved in the review and approval of the detailed monthly invoices sent by B,C&D to the Foundation. In their capacity with B,C&D, Mr. Brorby and Mr. Crozier do not participate in the preparation of the monthly statements of amounts billed to the Foundation. The other trustees (with Mr. Brorby and Mr. Crozier abstaining) have approved this arrangement with full knowledge of Mr. Brorby's and Mr. Crozier's position as a member of and a holder of a financial interest in B,C&D. Several written opinions have been obtained from well recognized independent accounting and consulting firms as to the reasonableness of the legal fees being paid to B,C&D by the Foundation. In addition, all steps listed in the regulations under IRC Section 4958 (including approval by a compensation committee composed of disinterested persons) have been taken to obtain the rebuttable presumption that compensation paid to B,C&D is reasonable. More specifically, the Foundation has periodically engaged an independent consulting firm to review the legal fees paid to B,C&D. Such consulting firm examines the relevant facts and collects information and data from the Foundation and B,C&D. It also collects and analyzes compensation data from a peer group of comparable unrelated attorneys and law firms that it selects for comparability purposes. Such consulting firm then renders a written report and opinion containing its conclusions and recommendations. Such report (including a thorough description of the facts and the comparability analysis and data) is provided to the Foundations Compensation Committee. Such committee, which has the sole authority to approve the compensation arrangement with B,C&D (including hourly rates), constitutes an authorized body composed of persons that do not have a conflict of interest with respect to such compensation arrangements under the rules and requirements set forth in Reg. 53.4958-6(c)(1). The committee meets and reviews the consulting firms report and the comparability analysis and data. At the meeting, the committee has the opportunity to ask questions and request additional information from a Foundation representative on the committee (who recuses himself from the meeting before any action is taken). After review of the relevant documents and data and after deliberations, the independent committee members make the determination with respect to the amount and reasonableness of the compensation arrangement. Such determination is binding on B,C&D. Detailed minutes of each Compensation Committee meeting are contemporaneously prepared and maintained in the Foundations files.

Filing and Contact Details

Filer

Filer Name
Clayton Foundation For Research
EIN
74-1541767
Phone
7138175259
Address
One Riverway 1500, Houston, TX 77056

Signing Officer

Name
Jarred W Sloan
Title
President
Signed
2023-11-15

Organization Details

Principal Officer
Jarred W Sloan
Formed
1965
Legal Domicile
TX
Voting Board Members
5
Independent Board Members
0
Employees
57
Supplemental Narrative

Additional Explanations

Form 990, Part III, Line 4D

OTHER PROGRAM SERVICES 4: Engineered Proteases as the Next Generation of Protein Therapeutics at the University of Texas at Austin OTHER PROGRAM SERVICES 5: The Use of Light for Cardiological, Surgical, and Related Purposes at the University of Texas Health Science Center at San Antonio OTHER PROGRAM SERVICES 6: Electroceutical Sciences and Medicine at Dell Medical School at the University of Texas OTHER PROGRAM SERVICES 7: Discovering New Mechanisms and Therapeutics for Brain Injury at the University of Texas Southwestern Medical Center Dallas OTHER PROGRAM SERVICES 8: Identification of Host-based Antiviral Targets at the University of Texas Southwestern Medical Center Dallas OTHER PROGRAM SERVICES 9: Targeting Novel Tumor-intrinsic PD Pathways to Optimize Cancer lmmunotherapy at the University of Texas Health Science Center at San Antonio OTHER PROGRAM SERVICES 10: Vaccines, Diagnostics and Therapeutics for the Ehrlichioses at The Univerity of Texas Medical Branch at Galveston OTHER PROGRAM SERVICES 11: Antibody Discovery and Optimization Using the Eclonal Technology at The University of Texas at Austin OTHER PROGRAM SERVICES 12: Development of Biorepository and Novel Therapeutic Strategies for Hepatocellular Carcinoma at the University of Texas Health Science Center at San Antonio OTHER PROGRAM SERVICES 13: Developing Drug Delivery Systems for Testing Solid Tumors at Dell Medical School at the University of Texas OTHER PROGRAM SERVICES 14: Optimization and Charactorization of AAV for Gene Therapy at Dell Medical School at The University of Texas OTHER PROGRAM SERVICES 15: Grants

Form 990, Part XI, Line 9

Effect in change in accounting policy for building rent = $462664

Form 990, Part XI, Line 9

Postretirement health benefit charge = $1117368

Financial Statement Notes

Part V, Line 4: Intended uses of the endowment fund.

The Board of Trustees of the Foundation has interpreted the Uniform Prudent Management of Institutional Funds Act (UPMIFA) as requiring the preservation of the fair value of the donor contributions as of the contribution dates of the donor-restricted endowment funds. As a result of the interpretation, the Foundation classifies as permanently restricted net assets the original value of the donated contribution to the permanent endowment. Accordingly, only the income, including net realized and unrealized gains, is to be used for the Foundation's activities, except when such assets must be distributed in order to maintain the Foundation's qualification as a medical research organization as defined in the Internal Revenue Code and the regulations thereunder.

Part X : FIN48 Footnote

From the Federal Income Taxes section of the footnote to the audited financial statements: "The Foundation has no uncertain tax positions".

Part XI, Line 2D: Other revenue amounts included in F/S but not included on form 990

Revenue from controlled corporation $16000

Part XI, Line 4B: Other revenue amounts included on 990 but not included in F/S

Distribution from controlled corporation $6883 Transfer cash from remainder trusts $48463

Part XII, Line 2D: Other expenses and losses per audited F/S

Excess purch 57,931 over depre 138,726 $80795 Accrual for postretire. health benefit $52731 Expenses of controlled corporation $9117 Other components periodic retire. cost $-98336

Raw XML AppendixShowing 400 of 773 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd0false
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt05575165
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt07117332
IRS990/AccountsReceivableGrp/BOYAmt0270377
IRS990/AccountsReceivableGrp/EOYAmt0284990
IRS990/ActivitiesConductedPrtshpInd0false
IRS990/ActivityOrMissionDesc0The primary mission is to conduct medical research in conjunction with hospitals for the purpose of discovering the cause, prevention and cure of diseases for the benefit of mankind.
IRS990/AdvertisingGrp/TotalAmt00
IRS990/AllOtherExpensesGrp/ManagementAndGeneralAmt035467
IRS990/AllOtherExpensesGrp/ProgramServicesAmt0105406
IRS990/AllOtherExpensesGrp/TotalAmt0140873
IRS990/AnnualDisclosureCoveredPrsnInd0true
IRS990/AuditCommitteeInd0true
IRS990/BackupWthldComplianceInd0true
IRS990/BenefitsToMembersGrp/TotalAmt00
IRS990/BooksInCareOfDetail/PersonNm0Jarred W Sloan
IRS990/BooksInCareOfDetail/PhoneNum07138175565
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt0One Riverway Suite 1500
IRS990/BooksInCareOfDetail/USAddress/CityNm0Houston
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0TX
IRS990/BooksInCareOfDetail/USAddress/ZIPCd0770561904
IRS990/BusinessRlnWith35CtrlEntInd0true
IRS990/BusinessRlnWithFamMemInd0false
IRS990/BusinessRlnWithOrgMemInd0false
IRS990/CashNonInterestBearingGrp/BOYAmt01775261
IRS990/CashNonInterestBearingGrp/EOYAmt0572693
IRS990/ChangeToOrgDocumentsInd0false
IRS990/CntrctRcvdGreaterThan100KCnt01
IRS990/CollectionsOfArtInd0false
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt0271055
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt01310951
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt01582006
IRS990/CompDisqualPersonsGrp/ManagementAndGeneralAmt0159896
IRS990/CompDisqualPersonsGrp/ProgramServicesAmt0373091
IRS990/CompDisqualPersonsGrp/TotalAmt0532987
IRS990/CompensationFromOtherSrcsInd0false
IRS990/CompensationProcessCEOInd0true
IRS990/CompensationProcessOtherInd0true
IRS990/ConferencesMeetingsGrp/TotalAmt00
IRS990/ConflictOfInterestPolicyInd0true
IRS990/ConservationEasementsInd0false
IRS990/ConsolidatedAuditFinclStmtInd0true
IRS990/ContractorCompensationGrp/CompensationAmt0498737
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt0111 Congress Ave Suite 2250
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm0Austin
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd0TX
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd078701
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt0Brorby Crozier & Dobie PC
IRS990/ContractorCompensationGrp/ServicesDesc0Legal
IRS990/CreditCounselingInd0false
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt03825000
IRS990/CYGrantsAndSimilarPaidAmt0150000
IRS990/CYInvestmentIncomeAmt02387350
IRS990/CYOtherExpensesAmt03361518
IRS990/CYOtherRevenueAmt0296022
IRS990/CYProgramServiceRevenueAmt096250
IRS990/CYRevenuesLessExpensesAmt0-3401998
IRS990/CYSalariesCompEmpBnftPaidAmt06495102
IRS990/CYTotalExpensesAmt010006620
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt06604622
IRS990/DecisionsSubjectToApprovaInd0false
IRS990/DeductibleArtContributionInd0false
IRS990/DeductibleNonCashContriInd0false
IRS990/DelegationOfMgmtDutiesInd0false
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt09005
IRS990/DepreciationDepletionGrp/ProgramServicesAmt022046
IRS990/DepreciationDepletionGrp/TotalAmt031051
IRS990/Desc0The conduct of a longstanding research program at the University of Texas M. D. Anderson Cancer Center, the purpose of which is to design and develop novel targeted therapeutic agents that target a powerful human toxin to specifically destroy cancer cells for the treatment of numerous cancer targets and other disease indications. A number of collaborations have been undertaken with researchers at various institutions (e.g., University of California San Diego, Stanford University, Johns Hopkins). Patent applications have been filed by Research Development Foundation ("RDF"), a tax exempt supporting organization of the Foundation (see schedule R, Part III), on more than twenty discoveries, and a number of patents have been issued. Licensing efforts have been ongoing and have resulted in several prior and current licenses.
IRS990/DescribedInSection501c3Ind0true
IRS990/DisregardedEntityInd0false
IRS990/DocumentRetentionPolicyInd0true
IRS990/DonorAdvisedFundInd0false
IRS990/DonorRestrictionNetAssetsGrp/BOYAmt042224647
IRS990/DonorRestrictionNetAssetsGrp/EOYAmt040529994
IRS990/DonorRstrOrQuasiEndowmentsInd0true
IRS990/ElectionOfBoardMembersInd0false
IRS990/EmployeeCnt057
IRS990/EmploymentTaxReturnsFiledInd0true
IRS990/EngagedInExcessBenefitTransInd0false
IRS990/ExpenseAmt01006084
IRS990/FamilyOrBusinessRlnInd0true
IRS990/FederalGrantAuditRequiredInd0false
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt09940
IRS990/FeesForServicesAccountingGrp/ProgramServicesAmt039759
IRS990/FeesForServicesAccountingGrp/TotalAmt049699
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt0148
IRS990/FeesForServicesLegalGrp/ProgramServicesAmt0444
IRS990/FeesForServicesLegalGrp/TotalAmt0592
IRS990/FeesForServicesLobbyingGrp/TotalAmt00
IRS990/FeesForServicesManagementGrp/TotalAmt00
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt04144
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt024518
IRS990/FeesForServicesOtherGrp/TotalAmt028662
IRS990/FeesForServicesProfFundraising/TotalAmt00
IRS990/FeesForSrvcInvstMgmntFeesGrp/ManagementAndGeneralAmt0310415
IRS990/FeesForSrvcInvstMgmntFeesGrp/TotalAmt0310415
IRS990/ForeignActivitiesInd0true
IRS990/ForeignFinancialAccountInd0false
IRS990/ForeignGrantsGrp/TotalAmt00
IRS990/ForeignOfficeInd0false
IRS990/Form1098CFiledInd0false
IRS990/Form8282FiledCnt00
IRS990/Form8282PropertyDisposedOfInd0false
IRS990/Form8899Filedind0false
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt020.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt120.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt232.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt310.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt410.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt536.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt60.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt70.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt80.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt90.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt020.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt120.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt28.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt35.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt45.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt54.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt640.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt740.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt840.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt940.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd3X
IRS990/Form990PartVIISectionAGrp/OfficerInd4X
IRS990/Form990PartVIISectionAGrp/OfficerInd5X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt093530
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt193530
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt293530
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt348520
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt448520
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt584230
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt678460
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt773500
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt867881
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt967072
IRS990/Form990PartVIISectionAGrp/PersonNm0Jarred W Sloan
IRS990/Form990PartVIISectionAGrp/PersonNm1Robert M Wallace
IRS990/Form990PartVIISectionAGrp/PersonNm2Lynn P Carter
IRS990/Form990PartVIISectionAGrp/PersonNm3Thomas J Brorby
IRS990/Form990PartVIISectionAGrp/PersonNm4Brian W Crozier
IRS990/Form990PartVIISectionAGrp/PersonNm5Joan S Dunlap
IRS990/Form990PartVIISectionAGrp/PersonNm6Robert L Evans
IRS990/Form990PartVIISectionAGrp/PersonNm7Kimberly A Shipley
IRS990/Form990PartVIISectionAGrp/PersonNm8Lawrence H Cheung
IRS990/Form990PartVIISectionAGrp/PersonNm9Joshua T Chang
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt0257354
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt1190957
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt291375
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt391375
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt491375
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt553138
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt6198267
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt7165200
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt8106475
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt9101077
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt0365608
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt1432005
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt2531587
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt3232855
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt4232855
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt5183598
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt90
IRS990/Form990PartVIISectionAGrp/TitleTxt0Trustee, President, Treasurer
IRS990/Form990PartVIISectionAGrp/TitleTxt1Trustee, Vice President
IRS990/Form990PartVIISectionAGrp/TitleTxt2Trustee
IRS990/Form990PartVIISectionAGrp/TitleTxt3Trustee, Chairman
IRS990/Form990PartVIISectionAGrp/TitleTxt4Trustee
IRS990/Form990PartVIISectionAGrp/TitleTxt5Vice President, Secretary
IRS990/Form990PartVIISectionAGrp/TitleTxt6Assistant Treasurer
IRS990/Form990PartVIISectionAGrp/TitleTxt7Assistant Secretary
IRS990/Form990PartVIISectionAGrp/TitleTxt8Project Researcher
IRS990/Form990PartVIISectionAGrp/TitleTxt9Project Researcher
IRS990/Form990ProvidedToGvrnBodyInd0true
IRS990/FormationYr01965
IRS990/FormerOfcrEmployeesListedInd0false
IRS990/FSAuditedBasisGrp/ConsolidatedBasisFinclStmtInd0X
IRS990/FSAuditedInd0true
IRS990/FundraisingActivitiesInd0false
IRS990/GainOrLossGrp/SecuritiesAmt0407093
IRS990/GamingActivitiesInd0false
IRS990/GoverningBodyVotingMembersCnt05
IRS990/GrantsToDomesticIndividualsGrp/TotalAmt00
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt0150000
IRS990/GrantsToDomesticOrgsGrp/TotalAmt0150000
IRS990/GrantsToIndividualsInd0false
IRS990/GrantsToOrganizationsInd0true
IRS990/GrantToRelatedPersonInd0false
IRS990/GrossAmountSalesAssetsGrp/SecuritiesAmt01514939
IRS990/GrossReceiptsAmt07712468
IRS990/GroupReturnForAffiliatesInd0false
IRS990/IncludeFIN48FootnoteInd0true
IRS990/IncmFromInvestBondProceedsGrp/TotalRevenueColumnAmt00
IRS990/IndependentAuditFinclStmtInd0false
IRS990/IndependentVotingMemberCnt00
IRS990/IndivRcvdGreaterThan100KCnt06
IRS990/IndoorTanningServicesInd0false
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartXIInd0X
IRS990/InformationTechnologyGrp/TotalAmt00
IRS990/InsuranceGrp/ManagementAndGeneralAmt032910
IRS990/InsuranceGrp/ProgramServicesAmt0203682
IRS990/InsuranceGrp/TotalAmt0236592
IRS990/IntangibleAssetsGrp/EOYAmt00
IRS990/InterestGrp/TotalAmt00
IRS990/InventoriesForSaleOrUseGrp/EOYAmt00
IRS990/InvestmentIncomeGrp/ExclusionAmt01980257
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt01980257
IRS990/InvestmentInJointVentureInd0false
IRS990/InvestmentsOtherSecuritiesGrp/EOYAmt00
IRS990/InvestmentsProgramRelatedGrp/EOYAmt00
IRS990/InvestmentsPubTradedSecGrp/BOYAmt0112865433
IRS990/InvestmentsPubTradedSecGrp/EOYAmt082679826
IRS990/IRPDocumentCnt011
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt01492989
IRS990/LandBldgEquipBasisNetGrp/BOYAmt0145430
IRS990/LandBldgEquipBasisNetGrp/EOYAmt02941572
IRS990/LandBldgEquipCostOrOtherBssAmt04434561
IRS990/LegalDomicileStateCd0TX
IRS990/LessCostOthBasisSalesExpnssGrp/SecuritiesAmt01107846
IRS990/LoanOutstandingInd0false
IRS990/LobbyingActivitiesInd0false
IRS990/LocalChaptersInd0false
IRS990/MaterialDiversionOrMisuseInd0false
IRS990/MembersOrStockholdersInd0false
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd0true
IRS990/MinutesOfGoverningBodyInd0true
IRS990/MissionDesc0The primary mission is to conduct medical research in conjunction with hospitals for the purpose of discovering the cause, prevention and cure of diseases for the benefit of mankind. The secondary mission is to transfer the resulting medical research discoveries from the laboratory to the use of the general public by patenting and licensing such technology for devlopment into drugs or other products for the use and benefit of mankind through the Foundation's supporting entities.
IRS990/MoreThan5000KToIndividualsInd0false
IRS990/MoreThan5000KToOrgInd0false
IRS990/NetAssetsOrFundBalancesBOYAmt0139336829
IRS990/NetAssetsOrFundBalancesEOYAmt0105568431
IRS990/NetGainOrLossInvestmentsGrp/ExclusionAmt0407093
IRS990/NetGainOrLossInvestmentsGrp/TotalRevenueColumnAmt0407093
IRS990/NetIncmFromFundraisingEvtGrp/TotalRevenueColumnAmt00
IRS990/NetIncomeFromGamingGrp/TotalRevenueColumnAmt00
IRS990/NetIncomeOrLossGrp/TotalRevenueColumnAmt00
IRS990/NetRentalIncomeOrLossGrp/TotalRevenueColumnAmt00
IRS990/NetUnrlzdGainsLossesInvstAmt0-31946432
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt097112182
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt065038437
IRS990/NondeductibleContributionsInd0false
IRS990/OccupancyGrp/ManagementAndGeneralAmt0104729
IRS990/OccupancyGrp/ProgramServicesAmt0256404
IRS990/OccupancyGrp/TotalAmt0361133
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt019265
IRS990/OfficeExpensesGrp/ProgramServicesAmt047166
IRS990/OfficeExpensesGrp/TotalAmt066431
IRS990/OfficerMailingAddressInd0false
IRS990/OperateHospitalInd0false
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherAssetsTotalGrp/BOYAmt029680108
IRS990/OtherAssetsTotalGrp/EOYAmt026051698
IRS990/OtherChangesInNetAssetsAmt01580032
IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt0179361
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt0960774
IRS990/OtherEmployeeBenefitsGrp/TotalAmt01140135
IRS990/OtherExpensesGrp/Desc0Medical research supplies
IRS990/OtherExpensesGrp/Desc1Charge for research lab use
IRS990/OtherExpensesGrp/Desc2Equipment rental & maintenance
IRS990/OtherExpensesGrp/Desc3Research equipment
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt07899
IRS990/OtherExpensesGrp/ProgramServicesAmt01260743
IRS990/OtherExpensesGrp/ProgramServicesAmt1663631
IRS990/OtherExpensesGrp/ProgramServicesAmt273043
IRS990/OtherExpensesGrp/ProgramServicesAmt357931
IRS990/OtherExpensesGrp/TotalAmt01260743
IRS990/OtherExpensesGrp/TotalAmt1663631
IRS990/OtherExpensesGrp/TotalAmt280942
IRS990/OtherExpensesGrp/TotalAmt357931
IRS990/OtherRevenueTotalAmt00
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt0234937
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt02479033
IRS990/OtherSalariesAndWagesGrp/TotalAmt02713970
IRS990/OthNotesLoansReceivableNetGrp/EOYAmt00
IRS990/PartialLiquidationInd0false
IRS990/PaymentsToAffiliatesGrp/TotalAmt00
IRS990/PayPremiumsPrsnlBnftCntrctInd0false
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt015562
IRS990/PayrollTaxesGrp/ProgramServicesAmt0178171
IRS990/PayrollTaxesGrp/TotalAmt0193733
IRS990/PensionPlanContributionsGrp/ManagementAndGeneralAmt036805
IRS990/PensionPlanContributionsGrp/ProgramServicesAmt0295466
IRS990/PensionPlanContributionsGrp/TotalAmt0332271
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt00
IRS990/PoliticalCampaignActyInd0false
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt0175385
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt0154984
IRS990/PrincipalOfficerNm0Jarred W Sloan
IRS990/ProfessionalFundraisingInd0false
IRS990/ProgramServiceRevenueGrp/Desc0Sponsored Research
IRS990/ProgramServiceRevenueGrp/ExclusionAmt096250
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt096250
IRS990/ProgSrvcAccomActy2Grp/Desc0A research project at Baylor College of Medicine in gene and protein therapy focuses on inappropriate cell division and cell death within the human body. Much of the work is devoted to intraocular angiogenesis, with particular attention to: 1) the signals that control this process, 2) the development of animal models of human ocular disease, and 3) development of potential therapies. New targets have been identified and potential therapeutic agents are being developed and tested for the treatment of wet AMD. Patent applications have been filed by RDF, one of the Foundation's supporting entities, on several discoveries arising out of this research. Licensing efforts by RDF resulted in a license to a commercial company that, using project technology, completed a Phase I human clinical trial with gene therapy to treat wet age-related macular degeneration. The company continues to develop a therapeutic canidate based on the project technology to inhibit neovascularization of corneas following transplantation.
IRS990/ProgSrvcAccomActy2Grp/ExpenseAmt0932339
IRS990/ProgSrvcAccomActy3Grp/Desc0A research program at Baylor College of Medicine in Houston is directed toward glaucoma, the second leading cause of permanent blindness in the world. More than 3 million Americans live with glaucoma, and it is estimated that perhaps millions more remain undiagnosed. The research includes opportunities to treat intraocular pressure (IOP) in a more targeted way that is independent of current medical therapies. State of the art technologies have been developed and are being used to analyze and characterize the molecular changes associated with the early stages of the diseases. The researchers are optimistic that this approach will lead to the identification of new potential therapies for glaucoma.
IRS990/ProgSrvcAccomActy3Grp/ExpenseAmt0922141
IRS990/ProhibitedTaxShelterTransInd0false
IRS990/PYContributionsGrantsAmt07250000
IRS990/PYExcessBenefitTransInd0false
IRS990/PYGrantsAndSimilarPaidAmt050500
IRS990/PYInvestmentIncomeAmt03599544
IRS990/PymtTravelEntrtnmntPubOfclGrp/TotalAmt00
IRS990/PYOtherExpensesAmt03362890
IRS990/PYOtherRevenueAmt0133161
IRS990/PYRevenuesLessExpensesAmt0664956
IRS990/PYSalariesCompEmpBnftPaidAmt06904359
IRS990/PYTotalExpensesAmt010317749
IRS990/PYTotalRevenueAmt010982705
IRS990/QuidProQuoContributionsInd0false
IRS990/RcvblFromDisqualifiedPrsnGrp/EOYAmt00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd0false
IRS990/ReceivablesFromOfficersEtcGrp/EOYAmt00
IRS990/ReconcilationRevenueExpnssAmt0-3401998
IRS990/RegularMonitoringEnfrcInd0true
IRS990/RelatedEntityInd0true
IRS990/RelatedOrganizationCtrlEntInd0true
IRS990/RelatedOrganizationsAmt03825000
IRS990/ReportInvestmentsOtherSecInd0false
IRS990/ReportLandBuildingEquipmentInd0true
IRS990/ReportOtherAssetsInd0true
IRS990/ReportOtherLiabilitiesInd0false
IRS990/ReportProgramRelatedInvstInd0false
IRS990/RoyaltiesGrp/TotalAmt00
IRS990/RoyaltiesRevenueGrp/ExclusionAmt0296022
IRS990/RoyaltiesRevenueGrp/TotalRevenueColumnAmt0296022
IRS990/SavingsAndTempCashInvstGrp/EOYAmt00
IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt0Part I, Line 4: The Foundation's primary purpose is to directly engage in the continuous active conduct of medical research in conjunction with various nonprofit hospitals. The hospital locations where such research is conducted are The University of Texas M D Anderson Cancer Center (Houston, Texas), The University of Texas Medical Branch (Galveston, Texas), Baylor College of Medicine (Houston, Texas), The University of Texas Southwestern Medical Center (Dallas, Texas), The University of Texas Health Science Center at San Antonio and Dell Medical School at The University of Texas (Austin, Texas). Additional research is conducted at the University of Texas Austin under a research affiliation agreement with The University of Texas System ("System") that provides for collaboration with any of the System's component hospital institutions whenever appropriate to further the research.
IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc0Part I: Additional Information
IRS990ScheduleA/HospitalNameAndAddressGrp/CityNm0Houston
IRS990ScheduleA/HospitalNameAndAddressGrp/StateAbbreviationCd0TX
IRS990ScheduleA/HospitalNameAndAddressGrp/SupportedOrganizationName/BusinessNameLine1Txt0Baylor College of Medicine and Other Hospitals See Part VI
IRS990ScheduleA/MedicalResearchOrganizationInd0X
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd0true
IRS990ScheduleD/CYEndwmtFundGrp/BeginningYearBalanceAmt039166467
IRS990ScheduleD/CYEndwmtFundGrp/EndYearBalanceAmt039166467
IRS990ScheduleD/CYMinus1YrEndwmtFundGrp/BeginningYearBalanceAmt039166467
IRS990ScheduleD/CYMinus1YrEndwmtFundGrp/EndYearBalanceAmt039166467
IRS990ScheduleD/CYMinus2YrEndwmtFundGrp/BeginningYearBalanceAmt039166467
IRS990ScheduleD/CYMinus2YrEndwmtFundGrp/EndYearBalanceAmt039166467
IRS990ScheduleD/CYMinus3YrEndwmtFundGrp/BeginningYearBalanceAmt039166467
IRS990ScheduleD/CYMinus3YrEndwmtFundGrp/EndYearBalanceAmt039166467
IRS990ScheduleD/CYMinus4YrEndwmtFundGrp/BeginningYearBalanceAmt039166467
IRS990ScheduleD/CYMinus4YrEndwmtFundGrp/EndYearBalanceAmt039166467
IRS990ScheduleD/EndowmentsHeldRelatedOrgInd0false
IRS990ScheduleD/EndowmentsHeldUnrelatedOrgInd0false
IRS990ScheduleD/EquipmentGrp/BookValueAmt068241
IRS990ScheduleD/EquipmentGrp/DepreciationAmt0687878
IRS990ScheduleD/EquipmentGrp/OtherCostOrOtherBasisAmt0756119
IRS990ScheduleD/ExpensesNotReportedAmt044307
IRS990ScheduleD/ExpensesNotRptFinclStmtAmt0310415
IRS990ScheduleD/ExpensesSubtotalAmt09696205
IRS990ScheduleD/FootnoteTextInd0X
IRS990ScheduleD/InvestmentExpensesNotIncld2Amt0310415
IRS990ScheduleD/InvestmentExpensesNotIncldAmt0310415
IRS990ScheduleD/LeaseholdImprovementsGrp/BookValueAmt046138
IRS990ScheduleD/LeaseholdImprovementsGrp/DepreciationAmt0443978
IRS990ScheduleD/LeaseholdImprovementsGrp/OtherCostOrOtherBasisAmt0490116
IRS990ScheduleD/NetUnrealizedGainsInvstAmt0-31946432
IRS990ScheduleD/OtherAssetsOrgGrp/BookValueAmt01363527
IRS990ScheduleD/OtherAssetsOrgGrp/BookValueAmt1256270
IRS990ScheduleD/OtherAssetsOrgGrp/BookValueAmt224431901
IRS990ScheduleD/OtherAssetsOrgGrp/Desc0Charitable Remainder Trusts
IRS990ScheduleD/OtherAssetsOrgGrp/Desc1Controlled Corporation
IRS990ScheduleD/OtherAssetsOrgGrp/Desc2Limited Partnership Investments
IRS990ScheduleD/OtherExpensesIncludedAmt044307
IRS990ScheduleD/OtherLandBuildingsGrp/BookValueAmt02827193
IRS990ScheduleD/OtherLandBuildingsGrp/DepreciationAmt0361133
IRS990ScheduleD/OtherLandBuildingsGrp/OtherCostOrOtherBasisAmt03188326
IRS990ScheduleD/OtherRevenueAmt016000
IRS990ScheduleD/OtherRevenuesNotIncludedAmt055346
IRS990ScheduleD/PrmnntEndowmentBalanceEOYPct01.00000
IRS990ScheduleD/RelatedOrgListSchRInd0false

Document Assets

No mirrored PDF or thumbnail assets are attached yet.